You have 9 free searches left this month | for more free features.

Condition

Lupus Erythematosus, Systemic (1)

Primary Sjogren's Syndrome (1)

Systemic Lupus Erythematosus (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Eli Lilly and Company (2)

Stanford University (1)

Collaborator

Intervention

ly3361237 (3)

placebo (2)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

ly3361237

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Primary Sjogren's Syndrome Trial (LY3361237)

Not yet recruiting

Primary Sjogren's Syndrome

LY3361237

(no location specified)

Mar 20, 2023

Systemic Lupus Erythematosus Trial in Worldwide (LY3361237, Placebo)

Recruiting

Systemic Lupus Erythematosus

LY3361237
Placebo

Mesa, Arizona
+49 more

Jan 17, 2023

Lupus Erythematosus, Systemic Trial in United States (LY3361237, Placebo)

Completed

Lupus Erythematosus, Systemic

LY3361237
Placebo

Anniston, Alabama
+8 more

Mar 3, 2021